tiprankstipranks
Trending News
More News >
CSPC Pharmaceutical Group Limited (HK:1093)
:1093

Compare CSPC Pharmaceutical Group (1093) vs. Competitors

Compare
27 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
CSPC Pharmaceutical Group
HK$9.60
$110.43B
29.59
115.25%
12 Buy
1 Hold
3 Sell
Moderate Buy
Sino Biopharmaceutical
HK$6.83
HK$118.75B
30.78
135.46%
2 Buy
0 Hold
0 Sell
Moderate Buy
Innovent Biologics
HK$81.10
HK$140.68B
109.18
145.39%
5 Buy
0 Hold
0 Sell
Strong Buy
Sinopharm Group Co
HK$20.28
HK$65.16B
9.00
1.61%
0 Buy
0 Hold
1 Sell
Moderate Sell
Wuxi Biologics (Cayman)
HK$37.00
$152.94B
33.19
100.87%
3 Buy
0 Hold
0 Sell
Strong Buy
Hansoh Pharmaceutical Group Company Limited
HK$38.60
HK$233.73B
44.35
115.88%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1093
CSPC Pharmaceutical Group
9.60
5.24
120.44%
HK:1177
Sino Biopharmaceutical
6.64
3.82
135.46%
HK:1801
Innovent Biologics
81.10
48.35
147.63%
HK:1099
Sinopharm Group Co
20.88
1.55
8.04%
HK:2269
Wuxi Biologics (Cayman)
37.00
18.52
100.22%
HK:3692
Hansoh Pharmaceutical Group Company Limited
38.60
21.00
119.32%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts